E-ISSN: 1305-3612
    Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B
    PDF
    Cite
    Share
    Request
    Abdominal Imaging - Original Article
    VOLUME: 28 ISSUE: 1
    P: 5-11
    January 2022

    Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B

    Diagn Interv Radiol 2022;28(1):5-11
    DOI: 10.5152/dir.2021.21471
    Zhongxian Pan 1
    Zhujing Li 1
    Fanqi Meng 1
    Yuanming Hu 1
    Xiaoyong Zhang 2
    Yueyao Chen 1
    1. Department of Radiology, Shenzhen Traditional Chinese Medicine Hospital (The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine), Shenzhen, China
    2. MR Collaborations, Siemens Healthcare Ltd., Shenzhen, China
    No information available.
    No information available
    Received Date: 05.05.2021
    Accepted Date: 01.09.2021
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE:

    We aimed to evaluate the diagnostic performance of apparent diffusion coefficient (ADC) in assessing liver fibrosis after correcting for the effects of hepatic steatosis or iron deposition.

    METHODS:

    Seventy-three patients with chronic hepatitis B (CHB) were included in this retrospective study. The aspartate aminotransferase-to-platelet ratio index (APRI) was calculated for classification of the fibrosis grade. Significant fibrosis and cirrhosis were diagnosed with the APRI. The proton density fat fraction (PDFF), R2*, and ADC values were measured. The impact of the PDFF and R2* on the ADC was analyzed. The PDFF- and R2*-corrected ADC values (ADCPDFF and ADCR2*) were calculated according to linear regression equations. The diagnostic performance of uncorrected ADC (ADCu), ADCPDFF and ADCR2* in predicting significant fibrosis and cirrhosis was assessed, and the area under the curve (AUC) values were compared.

    RESULTS:

    Among the 73 patients in this study, the mean ADC was 0.866 ± 0.084×10-3 mm2/s, the mean R2* was 60.24 (42.77, 85.37) 1/s, and the mean PDFF was 2.90% (1.60%- 4.80%). The ADC was negatively correlated with the PDFF (r= -0.298, P = .010) and R2* (r = -0.457, P < .001). Linear regression analysis showed that the PDFF and R2* were independent factors of the ADC (β= -0.315, P = .007, R2= 0.099 and β= -0.493, P < .001, R2= 0.243, respectively). Compared with the uncorrected ADC (r= -0.307, P = .022), the correlation between the ADCPDFF and fibrosis grade increased (r= -0.513, P < .001), and the correlation between the ADCR2* and fibrosis grade decreased (r=-0.168, P = .215). The AUC of the ADCPDFF was significantly larger than that of the ADCu in the diagnosis of significant fibrosis and cirrhosis, which increased from 0.68 to 0.81 (P = .003) for predicting significant fibrosis and from 0.75 to 0.84 (P = .009) for predicting cirrhosis. The AUCs for the ADCR2* in the diagnosis of significant fibrosis and cirrhosis were both lower than that for the uncorrected ADC (P = .206 and P = .109, respectively).

    CONCLUSION:

    After correcting for the effects of steatosis, the diagnostic performance of the ADC for signifi-cant fibrosis and cirrhosis increased. The ADC corrected for the effects of steatosis may be more reliable for identifying liver fibrosis.

    References

    2024 ©️ Galenos Publishing House